Amgen’s Bone Drug Cleared by U.S. for Osteoporosis
Business Week Tuesday 1st June, 2010
June 1 (Bloomberg) -- Amgen Inc.’s bone-strengthening drug denosumab, the focus of the largest development program in the company’s history, was cleared by U.S. regulators for use in older...

Comments
No comments yet for this story